129 related articles for article (PubMed ID: 12411546)
1. PET imaging drug distribution after intratumoral injection: the case for (124)I-iododeoxyuridine in malignant gliomas.
Roelcke U; Hausmann O; Merlo A; Missimer J; Maguire RP; Freitag P; Radü EW; Weinreich R; Gratzl O; Leenders KL
J Nucl Med; 2002 Nov; 43(11):1444-51. PubMed ID: 12411546
[TBL] [Abstract][Full Text] [Related]
2. Imaging brain tumor proliferative activity with [124I]iododeoxyuridine.
Blasberg RG; Roelcke U; Weinreich R; Beattie B; von Ammon K; Yonekawa Y; Landolt H; Guenther I; Crompton NE; Vontobel P; Missimer J; Maguire RP; Koziorowski J; Knust EJ; Finn RD; Leenders KL
Cancer Res; 2000 Feb; 60(3):624-35. PubMed ID: 10676646
[TBL] [Abstract][Full Text] [Related]
3. Imaging of brain tumor proliferative activity with iodine-131-iododeoxyuridine.
Tjuvajev JG; Macapinlac HA; Daghighian F; Scott AM; Ginos JZ; Finn RD; Kothari P; Desai R; Zhang J; Beattie B
J Nucl Med; 1994 Sep; 35(9):1407-17. PubMed ID: 8071684
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral administration of 5-[123I]iodo-2'-deoxyuridine in a patient with a brain tumor.
Kassis AI; Tumeh SS; Wen PY; Baranowska-Kortylewicz J; Van den Abbeele AD; Zimmerman RE; Carvalho PA; Garada BM; DeSisto WC; Bailey NO; Castronovo FP; Mariani G; Black PM; Adelstein SJ
J Nucl Med; 1996 Apr; 37(4 Suppl):19S-22S. PubMed ID: 8676198
[TBL] [Abstract][Full Text] [Related]
5. Iododeoxyuridine uptake and retention as a measure of tumor growth.
Tjuvajev J; Muraki A; Ginos J; Berk J; Koutcher J; Ballon D; Beattie B; Finn R; Dahighian F; Blasberg R
J Nucl Med; 1993 Jul; 34(7):1152-62. PubMed ID: 8315494
[TBL] [Abstract][Full Text] [Related]
6. Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical study.
Schulz CA; Mehta MP; Badie B; McGinn CJ; Robins HI; Hayes L; Chappell R; Volkman J; Binger K; Arzoomanian R; Simon K; Alberti D; Feierabend C; Tutsch KD; Kunugi KA; Wilding G; Kinsella TJ
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1107-15. PubMed ID: 15234045
[TBL] [Abstract][Full Text] [Related]
7. Pilot clinical trial of 5-[125I]iodo-2'-deoxyuridine in the treatment of colorectal cancer metastatic to the liver.
Macapinlac HA; Kemeny N; Daghighian F; Finn R; Zhang J; Humm J; Squire O; Larson SM
J Nucl Med; 1996 Apr; 37(4 Suppl):25S-29S. PubMed ID: 8676200
[TBL] [Abstract][Full Text] [Related]
8. Tumor localization and systemic absorption of intravesical instillation of radio-iodinated iododeoxyuridine in patients with bladder cancer.
Chiou RK; Dalrymple GV; Baranowska-Kortylewicz J; Holdeman KP; Schneiderman MH; Harrison KA; Taylor RJ
J Urol; 1999 Jul; 162(1):58-62. PubMed ID: 10379740
[TBL] [Abstract][Full Text] [Related]
9. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma.
Yuan X; Dillehay LE; Williams JR; Williams JA
Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303
[TBL] [Abstract][Full Text] [Related]
10. Tumor uptake and mitotic activity pattern of 5-[125I]iodo-2'- deoxyuridine after intravesical infusion in patients with bladder cancer.
Mariani G; Collecchi P; Baldassarri S; Di Luca L; Buralli S; Fontanini G; Baranowska-Kortylewicz J; Adelstein SJ; Kassis AI
J Nucl Med; 1996 Apr; 37(4 Suppl):16S-19S. PubMed ID: 8676197
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and dosimetry of iodine-125-IUdR in the treatment of colorectal cancer metastatic to liver.
Daghighian F; Humm JL; Macapinlac HA; Zhang J; Izzo J; Finn R; Kemeny N; Larson SM
J Nucl Med; 1996 Apr; 37(4 Suppl):29S-32S. PubMed ID: 8676201
[TBL] [Abstract][Full Text] [Related]
12. Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model.
Mairs RJ; Wideman CL; Angerson WJ; Whateley TL; Reza MS; Reeves JR; Robertson LM; Neshasteh-Riz A; Rampling R; Owens J; Allan D; Graham DI
Br J Cancer; 2000 Jan; 82(1):74-80. PubMed ID: 10638969
[TBL] [Abstract][Full Text] [Related]
13. Quantitative kinetics of [124I]FIAU in cat and man.
Jacobs A; Bräunlich I; Graf R; Lercher M; Sakaki T; Voges J; Hesselmann V; Brandau W; Wienhard K; Heiss WD
J Nucl Med; 2001 Mar; 42(3):467-75. PubMed ID: 11337525
[TBL] [Abstract][Full Text] [Related]
14. Unlabelled iododeoxyuridine increases the cytotoxicity and incorporation of [1251]-iododeoxyuridine in two human glioblastoma cell lines.
Xiao WH; Dupertuis YM; Mermillod B; Sun LQ; de Tribolet N; Buchegger F
Nucl Med Commun; 2000 Oct; 21(10):947-53. PubMed ID: 11130336
[TBL] [Abstract][Full Text] [Related]
15. Tumor targeting by intra-arterial infusion of 5-[123I]iodo-2'-deoxyuridine in patients with liver metastases from colorectal cancer.
Mariani G; Di Sacco S; Volterrani D; Di Luca L; Buralli S; Di Stefano R; Baranowska-Kortylewicz J; Bonora D; Matteucci F; Ricci S; Bellina CR; Falcone A; Salvadori PA; Mosca F; Adelstein SJ; Kassis AI
J Nucl Med; 1996 Apr; 37(4 Suppl):22S-25S. PubMed ID: 8676199
[TBL] [Abstract][Full Text] [Related]
16. Iodo-2'-deoxyuridine (IUdR) and 125IUdR loaded biodegradable microspheres for controlled delivery to the brain.
Reza MS; Whateley TL
J Microencapsul; 1998; 15(6):789-801. PubMed ID: 9818956
[TBL] [Abstract][Full Text] [Related]
17. Iododeoxyuridine (IUdR) combined with radiation in the treatment of malignant glioma: a comparison of short versus long intravenous dose schedules (RTOG 86-12).
Urtasun RC; Cosmatos D; DelRowe J; Kinsella TJ; Lester S; Wasserman T; Fulton DS
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):207-14. PubMed ID: 8407393
[TBL] [Abstract][Full Text] [Related]
18. Radiolabeled iododeoxyuridine: safety evaluation.
Harrison KA; Dalrymple GV; Baranowska-Kortylewicz J; Holdeman KP; Schneiderman MH; Lieberman RP; Sharp JG; Cohen SM; Leichner PK; Augustine SC; Tempero MA; Taylor RJ; Chiou RK
J Nucl Med; 1996 Apr; 37(4 Suppl):13S-16S. PubMed ID: 8676196
[TBL] [Abstract][Full Text] [Related]
19. Radiolabeled nucleoside analogs in cancer diagnosis and therapy.
Kassis AI; Adelstein SJ; Mariani G
Q J Nucl Med; 1996 Sep; 40(3):301-19. PubMed ID: 8961807
[TBL] [Abstract][Full Text] [Related]
20. Tumor targeting potential and metabolism of 5-[125I]iodo-2'-deoxyuridine injected intratumorally in patients with breast cancer.
Mariani G; Collecchi P; Giuliani L; Baranowska-Kortylewicz J; Di Luca L; Meucci G; Viacava P; Van den Abbeele AD; Salvadori PA; Di Sacco S
Ann N Y Acad Sci; 1993 Nov; 698():204-11. PubMed ID: 8279758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
